세계의 폐암 수술 시장 보고서(2025년)

Lung cancer surgery is a procedure aimed at removing cancerous tissue from the lungs. It is generally performed when the cancer is localized within the lung and has not extensively spread. The primary objective is to fully excise the tumor along with affected lung tissue to halt cancer progression or recurrence.

The main categories of lung cancer surgery include thoracotomy and minimally invasive techniques. Thoracotomy involves making an incision in the chest wall to access the lungs or other chest organs. Procedures under this umbrella include lobectomy, segmentectomy, pneumonectomy, sleeve resection, and extended resection. These surgeries utilize various tools and technologies such as thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, surgical energy devices including advanced bipolar and ultrasonic instruments-and more. These products are distributed through channels like direct tenders, retail sales, and online platforms. Key end users consist of hospitals, ambulatory surgical centers, academic and research institutions, specialty cancer care centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The lung cancer surgery market research report is one of a series of new reports from The Business Research Company that provides lung cancer surgery market statistics, including lung cancer surgery industry global market size, regional shares, competitors with a lung cancer surgery market share, detailed lung cancer surgery market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer surgery industry. The lung cancer surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lung cancer surgery market size has grown strongly in recent years. It will grow from $5.07 billion in 2024 to $5.33 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. Growth during the historic period can be attributed to the high prevalence of smoking, increasing incidence of lung cancer, expansion of hospital infrastructure, broader insurance coverage, and enhanced expertise among surgeons.

The lung cancer surgery market size is expected to see steady growth in the next few years. It will grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. Growth in the forecast period is expected to be driven by the aging global population, an increase in non-small cell lung cancer cases, rising awareness in emerging markets, the expansion of robotic surgery platforms, and greater investment in cancer care. Key trends during this period include robotic-assisted thoracic surgery, the application of augmented reality in surgery, the use of 3D printing for surgical simulation, artificial intelligence for surgical planning, and the development of smart surgical instruments.

The rising incidence of lung cancer is expected to drive the growth of the lung cancer surgery market in the future. Lung cancer involves the uncontrolled proliferation of abnormal cells in one or both lungs, which can disrupt normal lung function. The increase in lung cancer cases is linked to prolonged exposure to air pollution and fine particulate matter, as these tiny particles penetrate deep into the lungs, causing inflammation, cellular damage, and mutations that may lead to cancer. Lung cancer surgery plays a crucial role in reducing lung cancer-related mortality by enabling early removal of malignant tumors before they spread or worsen. For example, in June 2025, the Centers for Disease Control and Prevention, a US federal agency, reported that lung cancer caused 131,584 deaths in the United States in 2023, following 218,893 newly diagnosed cases in 2022. Therefore, the rising occurrence of lung cancer is fueling the lung cancer surgery market.

Leading companies in the lung cancer surgery market are focusing on developing innovative technologies like robotic-assisted surgeries to improve surgical accuracy, shorten recovery periods, and enhance patient outcomes. Robotic-assisted surgeries involve minimally invasive procedures performed with robotic systems controlled by surgeons, offering increased precision, fewer complications, and better recovery results. For instance, in March 2025, Johnson & Johnson MedTech, a US medical device and technology company, announced regulatory clearance of the MONARCH QUEST robotic-assisted bronchoscopy platform under U.S. 510(k). This platform provides improved reach and stability to access small, hard-to-reach lung nodules, aiding earlier diagnosis of lung cancer. Its advanced maneuverability and integration with imaging technologies allow for more precise biopsies while reducing patient discomfort. Designed to expand procedural capabilities and streamline workflows, the platform supports greater clinical confidence and consistency across a broad range of bronchoscopic procedures.

In June 2023, AstraZeneca Pharma India Ltd., an India-based pharmaceutical manufacturer, partnered with Rajiv Gandhi Cancer Institute and Research Center to enhance lung cancer diagnostic capabilities by establishing a Center of Excellence focused on advancing early and accurate testing. This collaboration seeks to improve patient outcomes by facilitating timely diagnosis, increasing access to advanced testing technologies, and supporting personalized treatment strategies for lung cancer. Rajiv Gandhi Cancer Institute and Research Center, based in India, provides thoracic surgery services, including minimally invasive methods such as video-assisted thoracoscopic surgery (VATS) and robotic surgery for lung cancer.

Major players in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC.

North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lung cancer surgery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lung cancer surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lung cancer surgery market consists of revenues earned by entities providing services such as preoperative and postoperative care, follow-up and monitoring and surgical procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer surgery market includes sales of products such as surgical instruments, stapling devices, electrosurgical units, thoracoscopes, and robotic surgical systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lung Cancer Surgery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lung cancer surgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lung cancer surgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lung cancer surgery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Thoracotomy; Minimally Invasive Surgeries
• 2) By Procedure: Lobectomy; Segmentectomy; Pneumonectomy; Sleeve Resection; Extended Reserction
• 3) By Product: Thoracoscopes; Mediastinoscopes; Bronchoscopes; Robotic-Assistes Thoracic Surgery Systems; Surgical Staplers; Surgical Energy Instruments; Advanced Energy Instruments; Advanced Bipolar Instruments; Ultrasonic Instruments
• 4) By Distribution Channels: Direct Tender; Retail Sales; Online Sales; Other Channels
• 5) By End User: Hospitals; Ambulatory And Surgical Centres; Academic And Research Institutes; Specialiaty Cancer Care Centre; Other End Users
• Subsegments:
• 1) By Thoracotomy: Lobectomy; Pneumonectomy; Segmentectomy; Wedge Resection
• 2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS); Robotic-Assisted Surgery
• Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthcare GmbH; Fujifilm Holdings Corporation; GE Healthcare Technologies Inc.; B. Braun Melsungen AG; Olympus Corporation; Intuitive Surgical Inc.; Teleflex Incorporated; Varian Medical Systems Inc.; Karl Storz SE; Lepu Medical Technology (Beijing) Co. Ltd.; Ambu A/S; Accuray Incorporated; KLS Martin Group; Richard Wolf GmbH; Ethicon Inc.; AngioDynamics Inc.; Ackermann Instrument GmbH; Scanlan International Inc.; Sontec Instruments Inc.; Covidien LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lung Cancer Surgery Market Characteristics

3. Lung Cancer Surgery Market Trends And Strategies

4. Lung Cancer Surgery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lung Cancer Surgery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lung Cancer Surgery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lung Cancer Surgery Market Growth Rate Analysis
• 5.4. Global Lung Cancer Surgery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lung Cancer Surgery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lung Cancer Surgery Total Addressable Market (TAM)

6. Lung Cancer Surgery Market Segmentation

• 6.1. Global Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thoracotomy
• Minimally Invasive Surgeries
• 6.2. Global Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lobectomy
• Segmentectomy
• Pneumonectomy
• Sleeve Resection
• Extended Reserction
• 6.3. Global Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thoracoscopes
• Mediastinoscopes
• Bronchoscopes
• Robotic-Assistes Thoracic Surgery Systems
• Surgical Staplers
• Surgical Energy Instruments
• Advanced Energy Instruments
• Advanced Bipolar Instruments
• Ultrasonic Instruments
• Other Products
• 6.4. Global Lung Cancer Surgery Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tender
• Retail Sales
• Online Sales
• Other Channels
• 6.5. Global Lung Cancer Surgery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory And Surgical Centres
• Academic And Research Institutes
• Specialiaty Cancer Care Centre
• Other End Users
• 6.6. Global Lung Cancer Surgery Market, Sub-Segmentation Of Thoracotomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lobectomy
• Pneumonectomy
• Segmentectomy
• Wedge Resection
• 6.7. Global Lung Cancer Surgery Market, Sub-Segmentation Of Minimally Invasive Surgeries, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Video-Assisted Thoracoscopic Surgery (VATS)
• Robotic-Assisted Surgery

7. Lung Cancer Surgery Market Regional And Country Analysis

• 7.1. Global Lung Cancer Surgery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lung Cancer Surgery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lung Cancer Surgery Market

• 8.1. Asia-Pacific Lung Cancer Surgery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lung Cancer Surgery Market

• 9.1. China Lung Cancer Surgery Market Overview
• 9.2. China Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lung Cancer Surgery Market

• 10.1. India Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lung Cancer Surgery Market

• 11.1. Japan Lung Cancer Surgery Market Overview
• 11.2. Japan Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lung Cancer Surgery Market

• 12.1. Australia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lung Cancer Surgery Market

• 13.1. Indonesia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lung Cancer Surgery Market

• 14.1. South Korea Lung Cancer Surgery Market Overview
• 14.2. South Korea Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lung Cancer Surgery Market

• 15.1. Western Europe Lung Cancer Surgery Market Overview
• 15.2. Western Europe Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lung Cancer Surgery Market

• 16.1. UK Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lung Cancer Surgery Market

• 17.1. Germany Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lung Cancer Surgery Market

• 18.1. France Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lung Cancer Surgery Market

• 19.1. Italy Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lung Cancer Surgery Market

• 20.1. Spain Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lung Cancer Surgery Market

• 21.1. Eastern Europe Lung Cancer Surgery Market Overview
• 21.2. Eastern Europe Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lung Cancer Surgery Market

• 22.1. Russia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lung Cancer Surgery Market

• 23.1. North America Lung Cancer Surgery Market Overview
• 23.2. North America Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lung Cancer Surgery Market

• 24.1. USA Lung Cancer Surgery Market Overview
• 24.2. USA Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lung Cancer Surgery Market

• 25.1. Canada Lung Cancer Surgery Market Overview
• 25.2. Canada Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lung Cancer Surgery Market

• 26.1. South America Lung Cancer Surgery Market Overview
• 26.2. South America Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lung Cancer Surgery Market

• 27.1. Brazil Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lung Cancer Surgery Market

• 28.1. Middle East Lung Cancer Surgery Market Overview
• 28.2. Middle East Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lung Cancer Surgery Market

• 29.1. Africa Lung Cancer Surgery Market Overview
• 29.2. Africa Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lung Cancer Surgery Market Competitive Landscape And Company Profiles

• 30.1. Lung Cancer Surgery Market Competitive Landscape
• 30.2. Lung Cancer Surgery Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lung Cancer Surgery Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Olympus Corporation
• 31.3. Intuitive Surgical Inc.
• 31.4. Teleflex Incorporated
• 31.5. Varian Medical Systems Inc.
• 31.6. Karl Storz SE
• 31.7. Lepu Medical Technology (Beijing) Co. Ltd.
• 31.8. Ambu A/S
• 31.9. Accuray Incorporated
• 31.10. KLS Martin Group
• 31.11. Richard Wolf GmbH
• 31.12. Ethicon Inc.
• 31.13. AngioDynamics Inc.
• 31.14. Ackermann Instrument GmbH
• 31.15. Scanlan International Inc.

32. Global Lung Cancer Surgery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lung Cancer Surgery Market

34. Recent Developments In The Lung Cancer Surgery Market

35. Lung Cancer Surgery Market High Potential Countries, Segments and Strategies

• 35.1 Lung Cancer Surgery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lung Cancer Surgery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lung Cancer Surgery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer